RUSSO, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 4.782
NA - Nord America 4.530
EU - Europa 4.088
SA - Sud America 609
AF - Africa 135
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.163
Nazione #
US - Stati Uniti d'America 4.352
SG - Singapore 2.082
RU - Federazione Russa 1.671
IT - Italia 998
VN - Vietnam 984
CN - Cina 890
BR - Brasile 496
HK - Hong Kong 327
FR - Francia 226
DE - Germania 216
NL - Olanda 180
FI - Finlandia 178
IE - Irlanda 140
SE - Svezia 121
CA - Canada 120
GB - Regno Unito 107
IN - India 65
JP - Giappone 64
TR - Turchia 55
UA - Ucraina 55
BD - Bangladesh 47
CI - Costa d'Avorio 43
KR - Corea 40
PL - Polonia 36
AR - Argentina 35
ZA - Sudafrica 33
MX - Messico 32
ES - Italia 28
PH - Filippine 25
IQ - Iraq 24
PK - Pakistan 21
TH - Thailandia 21
AT - Austria 20
CZ - Repubblica Ceca 19
EC - Ecuador 19
AE - Emirati Arabi Uniti 17
VE - Venezuela 16
TW - Taiwan 15
AU - Australia 11
EE - Estonia 11
ID - Indonesia 11
LT - Lituania 11
CO - Colombia 10
EG - Egitto 10
MT - Malta 10
PY - Paraguay 10
BG - Bulgaria 9
BE - Belgio 8
HU - Ungheria 8
MA - Marocco 8
NP - Nepal 8
UZ - Uzbekistan 8
AM - Armenia 7
CL - Cile 7
IL - Israele 7
JO - Giordania 7
KZ - Kazakistan 7
PE - Perù 6
SA - Arabia Saudita 6
BO - Bolivia 5
KE - Kenya 5
MY - Malesia 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
BH - Bahrain 4
GR - Grecia 4
HN - Honduras 4
JM - Giamaica 4
MK - Macedonia 4
PT - Portogallo 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GA - Gabon 3
IR - Iran 3
LB - Libano 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AL - Albania 2
BZ - Belize 2
ET - Etiopia 2
EU - Europa 2
GH - Ghana 2
GN - Guinea 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
OM - Oman 2
PG - Papua Nuova Guinea 2
Totale 14.128
Città #
Singapore 993
San Jose 620
Chandler 457
Moscow 414
Ashburn 386
Hong Kong 319
Beijing 293
Naples 276
Ho Chi Minh City 275
Hanoi 202
Amsterdam 150
Santa Clara 132
Los Angeles 126
Napoli 121
Hefei 113
Millbury 104
Lauterbourg 100
The Dalles 100
Princeton 81
New York 80
Dallas 78
Council Bluffs 73
Munich 72
Nanjing 72
Boston 67
Dong Ket 66
Jacksonville 60
Tokyo 56
Turku 56
Des Moines 53
Buffalo 49
Wilmington 46
Da Nang 45
Ottawa 45
São Paulo 43
Redondo Beach 42
Woodbridge 40
Haiphong 38
Orem 38
Helsinki 34
Frankfurt am Main 33
Seattle 32
Dublin 31
Denver 30
Dearborn 29
Warsaw 28
Chicago 27
Montreal 26
London 25
Seoul 24
Rome 23
Brooklyn 22
Houston 22
Atlanta 21
Lawrence 21
Nanchang 20
Stockholm 20
Milan 19
Toronto 18
Brno 17
Falkenstein 17
Cagliari 16
Rio de Janeiro 16
Ninh Bình 15
Shenyang 15
Menlo Park 14
San Francisco 14
Florence 13
Johannesburg 13
Phoenix 13
Poplar 13
Belo Horizonte 12
Boardman 12
Can Tho 12
Kronberg 12
Lappeenranta 12
Norwalk 12
Pomigliano d'Arco 12
Bacoli 11
Biên Hòa 11
Brasília 11
Changsha 11
Guangzhou 11
Tallinn 11
Ankara 10
Baghdad 10
Dhaka 10
Hebei 10
Jiaxing 10
Mumbai 10
Curitiba 9
Manchester 9
Melita 9
Mexico City 9
Paris 9
Pune 9
Shanghai 9
Thái Bình 9
Vienna 9
Charlotte 8
Totale 7.361
Nome #
Sex-related alterations of gut microbiota composition in the BTBR mouse model of autism spectrum disorder. 216
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis 211
Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD. 210
Chemopreventive effect of a milk whey by-product derived from Buffalo (Bubalus bubalis) in protecting from colorectal carcinogenesis 204
Pharmacokinetic characteristics and pharmacological profile of polyethylenglicole derivatives of palmitoylethanolamide (PEA) 193
Analgesic properties of N-(1-carbomyl 2-phenyl-ethyl)butyramide a new synthetic butyrate pro-drug in a model of acute and visceral pain 188
Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases 186
Palmitoylethanolamide treatment reduces blood pressure in spontaneously hypertensive rats: involvement of cytochrome p450-derived eicosanoids and Renin Angiotensin system 182
N-(1-carbamoyl-2-phenyl-ethyl) butyramide, a new synthetic butyrate derivative, reduces intestinal inflammation in dextran sodium sulphate-induced colitis 181
Butyrate as bioactive human milk protective component against food allergy 176
Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance 176
In vivo bioavailability and in vitro toxicological evaluation of the new butyric acid releaser N-(1-carbamoyl-2-phenyl-ethyl) butyramide 170
Characterization of New TRPM8 Modulators in Pain Perception 169
Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. 166
Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides 164
Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs 159
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations 157
Fatty acid acyl ethanolamines and PPAR-alpha in neurodegenerative and neurological diseases. Cellular models of neurodegeneration: preliminary data 153
Motor coordination and synaptic plasticity deficits are associated with increased cerebellar activity of NAPDH oxidase, CAMKII, and PKC at pre-plaque stage in the TgCRND8 mouse model of Alzheimer's disease. 153
Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms 153
Identification of an acetal derivative of the piperonyl methyl ketone in tablets seized for suspected drug trafficking 152
The Hepatic Mitochondrial Alterations Exacerbate Meta-Inflammation in Autism Spectrum Disorders 151
Peroxisome proliferator-activated receptor (PPAR)-alpha activation produces antidepressant-like effects in mice 151
Derivati polietilenglicolici di palmitoiletanolammide e aciletanolammidi analoghe 149
N-(1-carbamoyl-2-phenyl-ethyl) butyramide, a new synthetic butyrate derivative, reduces intestinal inflammation in dextran sodium sulfate-induced colitis 149
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy 147
Comparative therapeutic effects of sodium butyrate and BuToRo® in a model of nonalcoholic steatohepatitis in the young rat 147
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction 146
Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems. 146
Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial 145
Role of sodium butyrate and of its new prodrug N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA) in gastrointestinal transit, castor oil-induced diarrhoea, and croton oil-induced intestinal inflammation 143
Menthol-derived isoxazoles reduce capsaicin-induced allodynia in mice when applied as cutaneous gel 143
Ketogal Safety Profile in Human Primary Colonic Epithelial Cells and in Mice 142
Uncovering the role of the lipid receptor PPAR-alpha on higher brain functions 141
An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis 139
Preventive and curative effect of a synbiotic-based Lactobacillus paracasei B21060 on dextran sodium sulfate-induced colitis in mice 138
Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism 137
The Influence of Fiber on Gut Microbiota: Butyrate as Molecular Player Involved in the Beneficial Interplay Between Dietary Fiber and Cardiovascular Health 136
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug 135
N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress 134
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. 134
Improving in vivo conversion of oleuropein into hydroxytyrosol by oral granules containing probiotic Lactobacillus plantarum 299v and an Olea europaea standardized extract 134
Phaseolus vulgaris L. Extract: Alpha-amylase inhibition against metabolic syndrome in mice 134
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 133
Role of β3-adrenergic receptor in the modulation of synaptic transmission and plasticity in mouse cerebellar cortex 133
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 132
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease. 131
Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities 131
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. 129
Alginate-hyaluronan composite hydrogels accelerate wound healing process. 128
Palmitoylethanolamide, a lipid mediator, controls feeding behaviour and restores leptin sensitivity in ovariectomized obese rats 127
High Amylose Wheat Bread at Breakfast Increases Plasma Propionate Concentrations and Reduces the Postprandial Insulin Response to the Following Meal in Overweight Adults 126
Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice 126
Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice 125
Multiple drug-delivery strategies to enhance the pharmacological and toxicological properties of Mefenamic acid 124
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 124
Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs 123
role of neurosteroids in the analgesic and anti-hyperalgesic effect of pea 123
Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo 123
Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. 123
Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain. 121
Galactosyl prodrug of palmitoylethanolamide: Synthesis, stability, cell permeation and cytoprotective activity 121
Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404. 120
Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat 119
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 119
Galactosylated prodrugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug 118
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain 117
Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats 116
The search for the palmitoylethanolamide receptor. 113
Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. 113
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 113
Biological Profile of Two Gentiana lutea L. Metabolites Using Computational Approaches and In Vitro Tests 113
Pharmacological propertis of N-(1-carbomyl 2-phenyl-ethyl)butyramide a new synthetic butyrate pro-drug in inhibiting gastrointestinal transit, castor oil induced diarrhoea and dextran sulfate sodium (DSS)-induced colitis 111
central ppar-alpha activation reduces pain and hyperalgesia in mice via nuclear factor kb inhibitor 110
DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain 110
Synthesis and Pharmacological Evaluation of Analogs of Indole-Based Cannabimimetic Agents. 109
PALMITOYLETHANOLAMIDE, AN ENDOGENOUS PPAR-α AGONIST, MODULATES NEUROSTEROIDS DE NOVO SYNTHESIS 109
The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice 106
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. 106
Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations 106
Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. 105
The safety assessment of herbals with a new and ethical approach 105
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism 104
involvment of opioid and cannabinoid receptors in the oxytocin-induced antiyhperalgesic effect following icv administration 104
PALMITOYLETHANOLAMIDE INDUCES NEUROSTEROIDS SYNTHESIS IN C6 CELLS TROUGH PPAR-ALPHA DEPENDENT MECHANISM 103
Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents 102
Inhibition of C5aR1 as a promising approach to treat taxane-induced neuropathy 102
Phaseolus vulgaris extract ameliorates high-fat diet-induced colonic barrier dysfunction and inflammation in mice by regulating peroxisome proliferator-activated receptor expression and butyrate levels 100
naples pain conference (NPC) 99
PPAR-ALPHA AND NF-KB ACTIVATION. IMPLICATION IN PAIN PRINCIPIATION AND CHRONIC PAIN ESTABLISHMENT. 96
Modulation of Pain Sensitivity by Chronic Consumption of Highly Palatable Food Followed by Abstinence: Emerging Role of Fatty Acid Amide Hydrolase 94
Farmacologia delle aciletanolamidi: da cannabinomimetici a ppar-α agonisti nella modulazione del dolore 93
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. 93
Endogenous acylethanolamides modulates pain perception in mice 92
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in miceInvolvement of allopregnanolone biosynthesis. 91
INVOLVEMENT OF OPIOID AND CANNABINOID RECEPTORS IN THE OXYTOCIN-INDUCED ANTIHYPERALGESIC EFFECT FOLLOWING ICV ADMINISTRATION 91
Effects of a new synthetic butyrate derivate N-(1-Carbamoyl-2-phenyl-ethyl) butyramide on dextran sodium sulphate-induced colitis in mice 90
Palmitoylethanolamide Stimulation Induces Allopregnanolone Synthesis in C6 Cells and Primary Astrocytes: Involvement of Peroxisome-Proliferator Activated Receptor-α. 89
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647. 85
palmitoylethanolamide induces neurosteroids synthesis in c6 cells trought ppar-alpha dependent mechanism 85
Totale 13.194
Categoria #
all - tutte 44.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 0 0 77
2021/2022753 18 2 2 45 20 28 14 29 128 36 193 238
2022/20231.182 111 58 49 122 140 132 24 120 167 155 71 33
2023/2024689 29 112 105 52 30 61 46 103 11 19 82 39
2024/20253.639 184 138 18 67 90 171 438 266 204 338 1.403 322
2025/20266.575 716 403 726 670 1.218 265 756 315 760 508 180 58
Totale 14.387